135 related articles for article (PubMed ID: 38523226)
1. ASO Visual Abstract: Comparing Multivisceral Resection with Tumor-Only Resection of Liposarcoma Using the Win Ratio.
Gorji L; Nikahd M; Onuma A; Tsilimigras D; Hyer JM; Ruff S; Ilyas FZ; Contreras C; Grignol VP; Kim A; Pollock R; Pawlik TM; Beane JD
Ann Surg Oncol; 2024 Jun; 31(6):4152-4153. PubMed ID: 38523226
[No Abstract] [Full Text] [Related]
2. Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
Gorji L; Nikahd M; Onuma A; Tsilimigras D; Madison Hyer J; Ruff S; Ilyas FZ; Contreras C; Grignol VP; Kim A; Pollock R; Pawlik TM; Beane JD
Ann Surg Oncol; 2024 May; 31(5):3389-3396. PubMed ID: 38347333
[TBL] [Abstract][Full Text] [Related]
3. Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience.
Teixeira FR; Arakaki MS; Lima HVG; Ferreira FO; Menegozzo CAM; Silva ER; Montero EFS; Oya T; Lima LC; Akaishi EH; Utiyama EM
Surg Today; 2023 Oct; 53(10):1181-1187. PubMed ID: 37606758
[TBL] [Abstract][Full Text] [Related]
4. ASO Author Reflections: Multivisceral Versus Tumor-Only Resection in Retroperitoneal Liposarcoma.
Onuma A; Gorji L; Beane JD
Ann Surg Oncol; 2024 May; 31(5):3397-3398. PubMed ID: 38409372
[No Abstract] [Full Text] [Related]
5. Recurrent abdominal liposarcoma: analysis of 19 cases and prognostic factors.
Lu W; Lau J; Xu MD; Zhang Y; Jiang Y; Tong HX; Zhu J; Lu WQ; Qin XY
World J Gastroenterol; 2013 Jul; 19(25):4045-52. PubMed ID: 23840151
[TBL] [Abstract][Full Text] [Related]
6. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S
Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716
[TBL] [Abstract][Full Text] [Related]
7. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
8. [Results of surgical therapy of primary and recurrent retroperitoneal liposarcoma].
Hiller WF; Jähne J; Tusch G; Meyer HJ; Pichlmayr R
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():234-6. PubMed ID: 9101841
[TBL] [Abstract][Full Text] [Related]
9. Influence of biologic factors and anatomic site in completely resected liposarcoma.
Linehan DC; Lewis JJ; Leung D; Brennan MF
J Clin Oncol; 2000 Apr; 18(8):1637-43. PubMed ID: 10764423
[TBL] [Abstract][Full Text] [Related]
10. Management of high-grade retroperitoneal liposarcomas: personal experience.
Milone M; Pezzullo LS; Salvatore G; Pezzullo MG; Leongito M; Esposito I; Milone F
Updates Surg; 2011 Jun; 63(2):119-24. PubMed ID: 21455814
[TBL] [Abstract][Full Text] [Related]
11. Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma.
Spolverato G; Chiminazzo V; Lorenzoni G; Fiore M; Radaelli S; Sanfilippo R; Sangalli C; Barisella M; Callegaro D; Gronchi A
Eur J Surg Oncol; 2021 Dec; 47(12):3004-3010. PubMed ID: 34364722
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal sarcoma: is it time to change the surgical policy?
Mussi C; Colombo P; Bertuzzi A; Coladonato M; Bagnoli P; Secondino S; Navarria P; Morenghi E; Santoro A; Quagliuolo V
Ann Surg Oncol; 2011 Aug; 18(8):2136-42. PubMed ID: 21537866
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
14. Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening.
Rhu J; Cho CW; Lee KW; Park H; Park JB; Choi YL; Kim SJ
Medicine (Baltimore); 2017 Aug; 96(33):e7537. PubMed ID: 28816941
[TBL] [Abstract][Full Text] [Related]
15. Huge liposarcoma of the left retroperitoneum.
Goertz RS; Lenfers BH; Goertz GH
Am J Surg; 2009 Jun; 197(6):e59-60. PubMed ID: 19268897
[TBL] [Abstract][Full Text] [Related]
16. Multivisceral resection of retroperitoneal sarcomas in the elderly.
Smith HG; Thomas JM; Smith MJ; Hayes AJ; Strauss DC
Eur J Cancer; 2016 Dec; 69():119-126. PubMed ID: 27821314
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Surveillance After Resection of Retroperitoneal Well-Differentiated Liposarcoma: A Balancing Act Between Earlier Recurrence Detection, Patient Anxiety, and Health Care Resource Expenditure.
Keung EZ; Roland CL
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):748-749. PubMed ID: 32409970
[No Abstract] [Full Text] [Related]
18. Liposarcoma in patients younger than or equal to 22 years of age.
La Quaglia MP; Spiro SA; Ghavimi F; Hajdu SI; Meyers P; Exelby PR
Cancer; 1993 Nov; 72(10):3114-9. PubMed ID: 8221578
[TBL] [Abstract][Full Text] [Related]
19. [Midterm results after treatment of liposarcoma in the extremities].
Köhler T; Ziegler J; Hanisch U; Thielemann F; Baretton G; Günther KP
Z Orthop Ihre Grenzgeb; 2003; 141(6):684-9. PubMed ID: 14679435
[TBL] [Abstract][Full Text] [Related]
20. Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival.
Rhu J; Lee KW; Park JB; Kim SJ
Int J Clin Oncol; 2018 Aug; 23(4):765-774. PubMed ID: 29352382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
